PerkinElmer, Inc. provides a range of products and services primarily in the diagnostics, life sciences, and applied services markets. The company operates through two main segments: Discovery & Analytical Solutions, which contributes approximately 60% of revenue, and Diagnostics, which accounts for about 40%. The Discovery segment offers reagents, analytical technologies, and laboratory services for environmental and industrial applications, while the Diagnostics segment focuses on instruments and assays for genetic and infectious disease testing. Factors supporting the company's endurance include its established market presence and diverse product offerings, while potential limitations may arise from competition and reliance on regulatory approvals.
—
PerkinElmer, Inc. provides a range of products and services primarily in the diagnostics, life sciences, and applied services markets. The company operates through two main segments: Discovery & Analytical Solutions, which contributes approximately 60% of revenue, and Diagnostics, which accounts for about 40%. The Discovery segment offers reagents, analytical technologies, and laboratory services for environmental and industrial applications, while the Diagnostics segment focuses on instruments and assays for genetic and infectious disease testing. Factors supporting the company's endurance include its established market presence and diverse product offerings, while potential limitations may arise from competition and reliance on regulatory approvals.
—
Daily adjusted close
PerkinElmer, Inc. provides a range of products and services primarily in the diagnostics, life sciences, and applied services markets. The company operates through two main segments: Discovery & Analytical Solutions, which contributes approximately 60% of revenue, and Diagnostics, which accounts for about 40%. The Discovery segment offers reagents, analytical technologies, and laboratory services for environmental and industrial applications, while the Diagnostics segment focuses on instruments and assays for genetic and infectious disease testing. Factors supporting the company's endurance include its established market presence and diverse product offerings, while potential limitations may arise from competition and reliance on regulatory approvals.